Suppr超能文献

抑制Src酪氨酸激酶可刺激肾上腺雄激素的产生。

Inhibition of Src tyrosine kinase stimulates adrenal androgen production.

作者信息

Sirianni R, Carr B R, Andò S, Rainey W E

机构信息

Division of Reproductive Endocrinology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9032, USA.

出版信息

J Mol Endocrinol. 2003 Jun;30(3):287-99. doi: 10.1677/jme.0.0300287.

Abstract

A unique characteristic of the primate adrenal is the ability to produce 19-carbon steroids, often called the adrenal androgens. Although it is clear that the major human adrenal androgens, dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEA-S), are produced almost solely in the adrenal reticularis, the mechanisms regulating production are poorly understood. Herein, we tested the hypothesis that the Src family of tyrosine kinases are involved in the regulation of adrenal androgen production. The NCI-H295R human adrenal cell line and primary human adrenal cells in culture were used to study adrenal androgen production and expression of enzymes involved in steroidogenesis. To examine the role of Src tyrosine kinase, cells were treated with PP2, a specific Src inhibitor. Alternatively, adrenal cells were transfected with an expression vector containing a dominant-negative form of Src. PP2 treatment inhibited basal cortisol production while significantly increasing the production of DHEA and DHEA-S (together referred to as DHEA(S)) in both adrenal cell models. The effect of PP2 on steroidogenesis occurred along with a rapid induction of steroidogenic acute regulatory (StAR) protein synthesis as revealed by Western analysis. Treatment with PP2 also increased mRNA levels for StAR, and cholesterol side-chain cleavage (CYP11A) and 17alpha-hydroxylase/17,20-lyase (CYP17) enzymes. Treatment of adrenal cells with the cAMP agonist dibutyryladenosine cyclic monophosphate (dbcAMP), stimulated the production of cortisol and DHEA(S). However, treatment of adrenal cells with a combination of PP2 and dbcAMP enhanced the production of DHEA(S) while inhibiting cortisol production. During dbcAMP treatment PP2 was able to augment the expression of CYP17 and to inhibit the induction of 3beta-hydroxysteroid dehydrogenase type 2 (HSD3B2) levels. Increasing the CYP17 to HSD3B2 ratio is likely to promote the use of steroid precursors for the production of DHEA(S) and not for cortisol. Taken together these data suggest that the inhibition of Src tyrosine kinases causes adrenal cells to adopt a reticularis phenotype both by the production of DHEA(S) and by the steroidogenic enzymes expressed.

摘要

灵长类动物肾上腺的一个独特特征是能够产生19碳类固醇,通常称为肾上腺雄激素。虽然很明显,人类主要的肾上腺雄激素,脱氢表雄酮(DHEA)和硫酸脱氢表雄酮(DHEA-S)几乎完全在肾上腺网状带产生,但调节其产生的机制却知之甚少。在此,我们检验了酪氨酸激酶Src家族参与肾上腺雄激素产生调节的假说。利用NCI-H295R人肾上腺细胞系和培养的原代人肾上腺细胞来研究肾上腺雄激素的产生以及参与类固醇生成的酶的表达。为了研究Src酪氨酸激酶的作用,用特异性Src抑制剂PP2处理细胞。或者,用含有Src显性负性形式的表达载体转染肾上腺细胞。PP2处理在两种肾上腺细胞模型中均抑制基础皮质醇的产生,同时显著增加DHEA和DHEA-S(统称为DHEA(S))的产生。如蛋白质免疫印迹分析所示,PP2对类固醇生成的作用伴随着类固醇生成急性调节(StAR)蛋白合成的快速诱导。用PP2处理还增加了StAR、胆固醇侧链裂解酶(CYP11A)和17α-羟化酶/17,20-裂解酶(CYP17)的mRNA水平。用环磷酸腺苷(cAMP)激动剂二丁酰环磷腺苷(dbcAMP)处理肾上腺细胞,刺激了皮质醇和DHEA(S)的产生。然而,用PP2和dbcAMP联合处理肾上腺细胞增强了DHEA(S)的产生,同时抑制了皮质醇的产生。在dbcAMP处理期间,PP2能够增加CYP17的表达,并抑制2型3β-羟类固醇脱氢酶(HSD3B2)水平的诱导。增加CYP17与HSD3B2的比率可能会促进使用类固醇前体来产生DHEA(S),而不是用于产生皮质醇。综上所述,这些数据表明,抑制Src酪氨酸激酶会使肾上腺细胞通过产生DHEA(S)以及表达类固醇生成酶而呈现网状带细胞表型。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验